BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 10847314)

  • 1. Modafinil augmentation of antidepressant treatment in depression.
    Menza MA; Kaufman KR; Castellanos A
    J Clin Psychiatry; 2000 May; 61(5):378-81. PubMed ID: 10847314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression.
    Frye MA; Grunze H; Suppes T; McElroy SL; Keck PE; Walden J; Leverich GS; Altshuler LL; Nakelsky S; Hwang S; Mintz J; Post RM
    Am J Psychiatry; 2007 Aug; 164(8):1242-9. PubMed ID: 17671288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modafinil augmentation in depressed patients with partial response to antidepressants: a pilot study on self-reported symptoms covered by the Major Depression Inventory (MDI) and the Symptom Checklist (SCL-92).
    Rasmussen NA; Schrøder P; Olsen LR; Brødsgaard M; Undén M; Bech P
    Nord J Psychiatry; 2005; 59(3):173-8. PubMed ID: 16208839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study.
    DeBattista C; Doghramji K; Menza MA; Rosenthal MH; Fieve RR;
    J Clin Psychiatry; 2003 Sep; 64(9):1057-64. PubMed ID: 14628981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-label study of adjunctive modafinil in patients with sedation related to serotonergic antidepressant therapy.
    Schwartz TL; Azhar N; Cole K; Hopkins G; Nihalani N; Simionescu M; Husain J; Jones N
    J Clin Psychiatry; 2004 Sep; 65(9):1223-7. PubMed ID: 15367049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Modafinil in the treatment of depression].
    Videbech P
    Ugeskr Laeger; 2012 Feb; 174(6):348-51. PubMed ID: 22310006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness.
    Fava M; Thase ME; DeBattista C; Doghramji K; Arora S; Hughes RJ
    Ann Clin Psychiatry; 2007; 19(3):153-9. PubMed ID: 17729016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.
    Fava M; Thase ME; DeBattista C
    J Clin Psychiatry; 2005 Jan; 66(1):85-93. PubMed ID: 15669893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Open-label study of adjunct modafinil for the treatment of patients with fatigue, sleepiness, and major depression treated with selective serotonin reuptake inhibitors.
    Konuk N; Atasoy N; Atik L; Akay O
    Adv Ther; 2006; 23(4):646-54. PubMed ID: 17050507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study.
    Thase ME; Fava M; DeBattista C; Arora S; Hughes RJ
    CNS Spectr; 2006 Feb; 11(2):93-102. PubMed ID: 16520686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modafinil as adjunctive therapy in depressed outpatients.
    Nasr S
    Ann Clin Psychiatry; 2004; 16(3):133-8. PubMed ID: 15517845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An open-label trial of modafinil augmentation in patients with partial response to antidepressant therapy.
    Markovitz PJ; Wagner S
    J Clin Psychopharmacol; 2003 Apr; 23(2):207-9. PubMed ID: 12640225
    [No Abstract]   [Full Text] [Related]  

  • 13. Modafinil treatment for fatigue in HIV+ patients: a pilot study.
    Rabkin JG; McElhiney MC; Rabkin R; Ferrando SJ
    J Clin Psychiatry; 2004 Dec; 65(12):1688-95. PubMed ID: 15641875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiating treatment with modafinil for control of excessive daytime sleepiness in patients switching from methylphenidate: an open-label safety study assessing three strategies.
    Thorpy MJ; Schwartz JR; Kovacevic-Ristanovic R; Hayduk R
    Psychopharmacology (Berl); 2003 Jun; 167(4):380-5. PubMed ID: 12709775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
    Black J; Houghton WC
    Sleep; 2006 Jul; 29(7):939-46. PubMed ID: 16895262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of daytime sleepiness in a depressive patient during adjunct treatment with modafinil.
    Holder G; Brand S; Hatzinger M; Holsboer-Trachsler E
    J Psychiatr Res; 2002; 36(1):49-52. PubMed ID: 11755461
    [No Abstract]   [Full Text] [Related]  

  • 17. Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials.
    Goss AJ; Kaser M; Costafreda SG; Sahakian BJ; Fu CH
    J Clin Psychiatry; 2013 Nov; 74(11):1101-7. PubMed ID: 24330897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modafinil treatment for fatigue in HIV/AIDS: a randomized placebo-controlled study.
    Rabkin JG; McElhiney MC; Rabkin R; McGrath PJ
    J Clin Psychiatry; 2010 Jun; 71(6):707-15. PubMed ID: 20492840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective chart review of the effects of modafinil on depression as monotherapy and as adjunctive therapy.
    Price CS; Taylor FB
    Depress Anxiety; 2005; 21(4):149-53. PubMed ID: 16035049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modafinil therapy for apathy in an elderly patient.
    Padala PR; Burke WJ; Bhatia SC
    Ann Pharmacother; 2007 Feb; 41(2):346-9. PubMed ID: 17264158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.